Market Cap | ₹12,055Cr |
ROE | 17.24% |
P/E Ratio(TTM) | 24.32 |
EPS(TTM) | 40.40 |
P/B Ratio | 4.28 |
Dividend Yield | 0.51% |
Industry P/E | 40.64 |
Book Value | 229.65 |
Debt to Equity | 0.02 |
Face Value | 2 |
Parent Organisation | Alivus Life Sciences |
Managing Director | Dr. Yasir Rawjee |
NSE Symbol | ALIVUS |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Cohance Lifesciences | NA (0.00%) | 102.84 | ||
JB Chemicals & Pharmaceuticals | NA (0.00%) | 39.38 | ||
Emcure Pharmaceuticals | NA (0.00%) | 33.75 | ||
Wockhardt | NA (0.00%) | -195.00 |